TY - JOUR
T1 - Recent Trends in Screening Breast MRI
AU - Lee, Michelle V.
AU - Aharon, Shani
AU - Kim, Kevin
AU - Sunn Konstantinoff, Katerina
AU - Appleton, Catherine M.
AU - Stwalley, Dustin
AU - Olsen, Margaret A.
N1 - Publisher Copyright:
© 2021 Society of Breast Imaging. All rights reserved.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Objective: The objective of this study was to assess trends in screening breast MRI utilization among privately insured women in the U.S. from 2007 to 2017. Methods: The utilization of screening breast MRI among women aged 25-64 years from January 1, 2007, to December 31, 2017, was obtained using the MarketScan Commercial Database. We used Current Procedural Terminology codes to exclude breast MRI exams performed in women with a new breast cancer diagnosis and in women imaged to assess response to neoadjuvant therapy in the preceding 90 days. During the 11-year study, 351 763 study-eligible women underwent 488 852 MRI scans. Results: An overall 55.0% increase in screening breast MRI utilization was observed over the study period, with a steadily increasing trend. The greatest annual increase in percent utilization was from 2007 to 2008 at 16.6%. The highest utilization rate was in 2017, in which 0.4% of women aged 25-64 years underwent screening breast MRI. Of the women who underwent screening MRI with sufficient follow-up, 76.5% underwent only one examination during the study period. Conclusion: Utilization of screening breast MRI has increased steadily in the past decade to a peak of 0.4% of adult women. However, an estimated 9% of U.S. women are eligible for high-risk breast MRI screening; thus, utilization falls short of optimal compliance. Further studies to evaluate the barriers to screening compliance may help optimize utilization.
AB - Objective: The objective of this study was to assess trends in screening breast MRI utilization among privately insured women in the U.S. from 2007 to 2017. Methods: The utilization of screening breast MRI among women aged 25-64 years from January 1, 2007, to December 31, 2017, was obtained using the MarketScan Commercial Database. We used Current Procedural Terminology codes to exclude breast MRI exams performed in women with a new breast cancer diagnosis and in women imaged to assess response to neoadjuvant therapy in the preceding 90 days. During the 11-year study, 351 763 study-eligible women underwent 488 852 MRI scans. Results: An overall 55.0% increase in screening breast MRI utilization was observed over the study period, with a steadily increasing trend. The greatest annual increase in percent utilization was from 2007 to 2008 at 16.6%. The highest utilization rate was in 2017, in which 0.4% of women aged 25-64 years underwent screening breast MRI. Of the women who underwent screening MRI with sufficient follow-up, 76.5% underwent only one examination during the study period. Conclusion: Utilization of screening breast MRI has increased steadily in the past decade to a peak of 0.4% of adult women. However, an estimated 9% of U.S. women are eligible for high-risk breast MRI screening; thus, utilization falls short of optimal compliance. Further studies to evaluate the barriers to screening compliance may help optimize utilization.
KW - breast MRI
KW - breast cancer screening
KW - high risk
UR - http://www.scopus.com/inward/record.url?scp=85130478529&partnerID=8YFLogxK
U2 - 10.1093/jbi/wbab088
DO - 10.1093/jbi/wbab088
M3 - Article
C2 - 35103253
AN - SCOPUS:85130478529
SN - 2631-6110
VL - 4
SP - 39
EP - 47
JO - Journal of Breast Imaging
JF - Journal of Breast Imaging
IS - 1
ER -